PRESS RELEASE
News
-
-
PRESS RELEASE
Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology
Tharimmune, Inc. announces preclinical data on novel dual-target biologics HS1940 and HS3215 using EpiClick™ Technology to address cancer treatment needs -
-
-
-
PRESS RELEASE
Orogen Royalties Announces Mineral Resource and Reserve Update on Producing Ermitaño Royalty Including Initial Inferred Resource for the Navidad Vein
Orogen Royalties Inc. announces mineral reserve and resource update for Ermitaño gold mine in Sonora, Mexico. Significant growth potential in Navidad vein system -
PRESS RELEASE
CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer
CureVac receives U.S. FDA clearance for phase 1 trial of mRNA immunotherapy in squamous NSCLC, a novel approach combining precision therapy with pembrolizumab -
-
PRESS RELEASE
Electric Metals' Long-standing, Integrated Domestic Manganese Strategy Validated by U.S. Policy Shift Aimed at Restoring American Industrial Independence
Electric Metals (USA) advances strategy for manganese production in response to new tariffs, focusing on U.S. supply chain for critical material -
